Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 1/20 | 0.47 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.47 |
| ▸ | P2RX7 | Q99572 | 6/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | SPR | P35270 | 1/20 | 0.39 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | VNN1 | O95497 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 3/20 | 0.37 |
| ▸ | ATR | Q13535 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.35 |
| ▸ | MTOR | P42345 | 2/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | MYT1 | Q01538 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3815730 | 0.87 | SCD (0.44) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL3818952 | 0.86 | SCD (0.43) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL3810702 | 0.83 | SCD (0.50) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL929838 | 0.83 | GRM5 (0.55) | SCDSCD5P2RX7VNN1GRM5 | |
| SCHEMBL3815980 | 0.83 | NAMPT (0.42) | P2RX7NAMPTSPRGRM5PIK3CA | |
| SCHEMBL4473093 | 0.81 | SCD (0.37) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL3813820 | 0.80 | SCD (0.47) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL3815162 | 0.76 | SCD (0.44) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL3818158 | 0.76 | SCD (0.43) | SCDSCD5P2RX7NAMPTSPR | |
| SCHEMBL3815966 | 0.74 | SPR (0.56) | SPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | claimed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |